Lipids
RSSArticles
-
Secondary Prevention with Flu Vaccine
-
Survival after Coronary Revascularization in the Elderly
-
Clinical Briefs in Primary Care Supplement
-
Left Atrial vs. Bi-Atrial Maze Operation
-
Clinical Briefs in Primary Care supplement
-
Pharmacology Watch
Beta-Blockers Therapy for the Treatment of Hypertension; Treatments for Acute Migraine; Statin Therapy for ACS Patients; The Correct Dosing for Onychomycosis; FDA Actions -
Pharmacology Watch: Menopausal Hormone Therapy and the Risk for VTE, AD
Menopausal hormone therapy and risk of VTE and AD; patients' understanding of chemotherapy benefits; and FDA actions. -
Left Atrial Appendage Exclusion Device for Protection From Thromboemboli
The left atrial appendage is thought to be the source of a large proportion of emboli in patients with nonvalvular atrial fibrillation. In this paper, Bartus and his colleagues describe an innovative new device that uses a combined transseptal-epicardial approach to ligate the left atrial appendage. -
NSAIDS Post Myocardial Infarction
The use of non-steroidal anti-inflammatory drugs (NSAIDs) early after myocardial infarction (MI) has been shown to increase the risk of death or recurrent MI, but little is known about the long-term risks. -
Bare-Metal or Everolimus-Eluting Stents in STEMI?
Drug-eluting stents (DES) reduce the rate of in-stent restenosis (ISR) compared to bare-metal stents (BMS). However, the first-generation DES had higher rates of late stent thrombosis than BMS, and this was more evident after primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI).